“A fundamental change in medical culture” is needed

Europe

Author: Geoffrey ChangPublished: 8 April 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

EPF-Stop-Blaming-Patients

A leading patient advocacy group is calling on health professionals to take more responsibility for improving medicine-taking behaviour among patients with chronic conditions such as Parkinson’s.

The European Patients Forum (EPF) wants professionals to be trained in shared decision-making and in communicating effectively with patients about treatment choices and goals.

The EPF is proposing a change in attitude from ‘blaming the patient’ to ‘working with the patient for better health outcomes’ – along with a change in terminology from ‘compliance’ to ‘adherence’ – in order to promote what it describes as “a neutral description of patients’ medicine-taking behaviour.”

Setting out its position in a newly published paper, the EPF stated: “An important part of self-management is the effective administering of medicines. Many patients, however, end up not taking their medicines in the way the prescriber instructs them. It’s a safety issue that carries large costs and risks to both the individual and health systems.”

Kaisa Immonen-Charalambous, EPF senior policy adviser, added: “Patients want clear and comprehensive information on medicines, of course. But information is merely a support tool. Even more important is that the health professionals have the right skills and attitudes. They need to believe that involving patients in decision-making promotes trust and honesty, and ultimately leads to better outcomes. We need to move towards a fundamental change in medical culture.”

Read the position paper here.

Go Back

Share this story

Comments


Related articles


cycle

Interviews

Alison Anderson: the “cyclopath”

We spoke to the campaigner who cycled 1,000 miles

READ MORE
Crowded sidewalk on Oxford Street in London

Special reports

Parkinson’s prevalence expected to increase by 18% in next seven years

Aging UK population could see increase in Parkinson’s over time

READ MORE
CVT-301 Inhaler lead

Advances

Fast-acting inhalable levodopa produces positive results in clinical trial

Is inhalable levodopa for treating Parkinson’s one step closer?

READ MORE